-- Robert Preidt
WEDNESDAY, Oct. 17 (HealthDay News) -- A man with Duchenne
muscular dystrophy who received a device to help his heart's left
ventricle pump blood throughout his body could represent a
breakthrough in the treatment of the disease, according to his
Jason Williams, 29, of Peebles, Ohio, is believed to be one of
the first U.S. patients with Duchenne muscular dystrophy to receive
an implanted ventricular assist device, the Cincinnati Children's
Hospital Medical Center team said.
Ventricular assist devices are mechanical pumps implanted in the
chest to help a weakened heart pump blood to the rest of the
Eighty percent of boys and men with Duchenne muscular dystrophy
die of heart failure, according to a medical center news release.
Due to the severity of their muscle disease, they are not typically
candidates for heart transplant or some other treatment options
available to patients with other types of muscular dystrophy.
"This is a major milestone in the care of Duchenne muscular dystrophy," Dr. John Lynn Jefferies, director of the heart failure and ventricular assist device programs at the Cincinnati Children's Heart Institute, said in the news release. "This treatment offers the possibility to change the outcome and the lives of these young men in a significant way that has never been realized up until now."
Duchenne muscular dystrophy is an inherited disorder. It affects
mostly males and many patients need a wheelchair before the age of
12. Patients with later stages of the disease experience severe
difficulty breathing and heart problems, and many patients die in
their late teens or early 20s.
Williams explained his decision to receive the ventricular
"I wanted to live longer with a better quality of life, and help other people -- those with Duchenne facing heart failure and death," Williams said in the news release. "I hope that doctors and surgeons can learn from my surgery and my recovery and be able to offer this treatment to other men and boys with Duchenne."
Each year, about 2,500 people worldwide are born with Duchenne
muscular dystrophy. By age 21, every Duchenne patient has a heart
muscle disease called dilated cardiomyopathy.
The U.S. National Human Genome Research Institute has more about
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.